Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82,773,190
-
Total 13F shares
-
56,388,612
-
Share change
-
-10,774,673
-
Total reported value
-
$263,332,828
-
Put/Call ratio
-
69%
-
Price per share
-
$4.67
-
Number of holders
-
229
-
Value change
-
-$55,730,958
-
Number of buys
-
108
-
Number of sells
-
109
Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q2 2024
As of 30 Jun 2024,
Editas Medicine, Inc. - Common Stock (EDIT) was held by
229 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,388,612 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Deep Track Capital, LP, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, Pictet Asset Management Holding SA, GOLDMAN SACHS GROUP INC, and Woodline Partners LP.
This page lists
229
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.